The Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke's Medical Center has begun enrolling patients in a clinical research study looking at an investigational drug in patients with malignant pleural mesothelioma who have started on chemotherapy or whose cancer has progressed after initial chemotherapy. Pleural mesothelioma is a rare and aggressive cancer that develops in the pleura, a thin layer of tissue that surrounds the lungs.

The Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke's Medical Center has begun enrolling patients in a clinical research study looking at an investigational drug in patients with malignant pleural mesothelioma who have started on chemotherapy or whose cancer has progressed after initial chemotherapy. Pleural mesothelioma is a rare and aggressive cancer that develops in the pleura, a thin layer of tissue that surrounds the lungs.